Abstract
CCHF is an acute, contagious and fatal disease that belongs to the viral hemorrhagic fever group. In case of delay in diagnosis, it carries a serious risk for healthcare professionals who have close contact with the patient. With this study, it is aimed to raise awareness on this issue by presenting a case of delayed diagnosis of CCHF due to its atypical clinical course so that healthcare personnel had close contact with the patient had to receive ribavirin prophylaxis.
Keywords
References
- Fillâtre P, Revest M, Tattevin P. Crimean-Congo hemorrhagic fever: An update. Med Mal Infect. 2019;49:574-85.
- Uyar Y, Çarhan A. Kırım Kongo Kanamalı ateşinin ülkemizdeki epidemiyolojisi. Türk Hij Den Biyol Derg. 2009; 66: 13-6
- Charrel RN, Attoui H, Butenko AM, et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect. 2004;10: 1040-55
- Rehman K, Bettani MAK, Veletzky L, et al. Outbreak of Crimean-Congo haemorrhagic fever with atypical clinical presentation in the Karak District of Khyber Pakhtunkhwa, Pakistan. Infect Dis Poverty 2018; 7:116
- Krüger HJ, De Wet R, Blumberg LH, et al. Atypical presentation of Crimean-Congo haemorrhagic fever: Lessons learned. S Afr Med J. 2019;109:91-4
- Elaldi N, Bodur H, Ascioglu S, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey. J Infect 2009; 58: 238– 44.
- Guven G, Talan L, Altintas ND, et al. An unexpected fatal CCHF case and management of exposed health care workers. Int J Infect Dis 2017;55: 118-21
- Guner R, Hasanoğlu I, Tasyaran MA, et al. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever? Vector-Borne and Zoonotic Diseases 2014;14: 601-5.
Abstract
KKKA viral hemorojik ateş grubunda yer alan, akut seyirli, bulaşıcı ve mortal bir hastalıktır. Tanı konulması gecikmesi durumunda hasta ile yakın teması olan sağlık çalışanları için ciddi risk taşımaktadır. Bu çalışmayla, atipik seyir nedeniyle geç tanı aldığından hasta ile yakın temas kuran sağlık personelinin ribavirin proflaksisi almak durumunda kaldığı bir KKKA olgusunu sunarak bu konudaki farkındalığı arttırmak amaçlanmıştır.
Ethical Statement
Hasta klinik takipleri sonrasıda exitus olduğundan hastadan vaka sunumu için onam alınamamıştır.
References
- Fillâtre P, Revest M, Tattevin P. Crimean-Congo hemorrhagic fever: An update. Med Mal Infect. 2019;49:574-85.
- Uyar Y, Çarhan A. Kırım Kongo Kanamalı ateşinin ülkemizdeki epidemiyolojisi. Türk Hij Den Biyol Derg. 2009; 66: 13-6
- Charrel RN, Attoui H, Butenko AM, et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect. 2004;10: 1040-55
- Rehman K, Bettani MAK, Veletzky L, et al. Outbreak of Crimean-Congo haemorrhagic fever with atypical clinical presentation in the Karak District of Khyber Pakhtunkhwa, Pakistan. Infect Dis Poverty 2018; 7:116
- Krüger HJ, De Wet R, Blumberg LH, et al. Atypical presentation of Crimean-Congo haemorrhagic fever: Lessons learned. S Afr Med J. 2019;109:91-4
- Elaldi N, Bodur H, Ascioglu S, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey. J Infect 2009; 58: 238– 44.
- Guven G, Talan L, Altintas ND, et al. An unexpected fatal CCHF case and management of exposed health care workers. Int J Infect Dis 2017;55: 118-21
- Guner R, Hasanoğlu I, Tasyaran MA, et al. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever? Vector-Borne and Zoonotic Diseases 2014;14: 601-5.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Infectious Diseases |
| Journal Section | Case Report |
| Authors | |
| Early Pub Date | March 28, 2024 |
| Publication Date | March 28, 2024 |
| Submission Date | December 11, 2023 |
| Acceptance Date | January 2, 2024 |
| Published in Issue | Year 2024 Volume: 5 Issue: 1 |
Cite
